Katherine A. Abrahams
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Mechanism of the M. tuberculosis DprE1-DprE2 epimerase complex and inhibition by anti-tubercular drugs.
Journal: Nature chemical biology
Published: May 09, 2026
Top five unanswered questions in bacterial cell wall research.
Journal: Cell surface (Amsterdam, Netherlands)
Published: November 27, 2023
Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis.
Journal: Microbiology (Reading, England)
Published: February 07, 2023
DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid.
Journal: Nature communications
Published: November 25, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
Journal: Antimicrobial agents and chemotherapy
Published: May 24, 2022
Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis.
Journal: ACS infectious diseases
Published: December 15, 2020
Synthesis and recycling of the mycobacterial cell envelope.
Journal: Current opinion in microbiology
Published: September 25, 2020
Anti-tubercular derivatives of rhein require activation by the monoglyceride lipase Rv0183.
Journal: Cell surface (Amsterdam, Netherlands)
Published: February 27, 2020
Development of a whole-cell high-throughput phenotypic screen to identify inhibitors of mycobacterial amino acid biosynthesis.
Journal: FASEB bioAdvances
Published: November 05, 2018
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface.
Journal: Scientific reports
Published: May 31, 2017
Last Updated: 09/26/2026